Birdwatch Note Rating
2023-03-16 02:45:06 UTC - NOT_HELPFUL
Rated by Participant: 57084AD91646B9C458BD94C70DE2128B0C4324E5EACF527329745F24B2A20BEE
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details